1. Executive Summary (Confidence: High)

Operating in the nexus of wealth management and high-tech innovation, Helvetic Trust provides high-net-worth individuals and families with exclusive access to the longevity sector. Its "Helvetic Ventures" instrument focuses on the "Advanced technologies" of life sciences and the "prolongation of life," managing mandates that typically exceed CHF 5 million to 10 million. By combining professional investment analysis with a target portfolio of 20–30 companies, Helvetic Trust enables private investors to achieve above-average returns in sectors that are traditionally inaccessible to the public market. With an international team and offices across Switzerland and in London, the firm acts as a specialized bridge between private capital and the most promising scientific developments in human healthspan.